Acute Effects of Intravenous Heroin on the Hypothalamic-Pituitary-Adrenal Axis Response: A Controlled Trial
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
Heroin dependence is associated with a stressful environment and with dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis. The present study examined the acute effects of intravenous heroin versus placebo on the HPA axis response in heroin-dependent patients. Twenty-eight heroin-dependent patients in heroin-assisted treatment and 20 age- and sex-matched healthy participants were included in a controlled trial in which patients were twice administered heroin or saline in a crossover design, and healthy controls were only administered saline. The HPA axis response was measured by adrenocorticotropic hormone (ACTH) levels and by cortisol levels in serum and saliva before and 20 and 60 minutes after substance administration. Craving, withdrawal, and anxiety levels were measured before and 60 minutes after substance application. Plasma concentrations of heroin and its main metabolites were assessed using high-performance liquid chromatography. Heroin administration reduces craving, withdrawal, and anxiety levels and leads to significant decreases in ACTH and cortisol concentrations (P < 0.01). After heroin administration, cortisol concentrations did not differ from healthy controls, and ACTH levels were significantly lower (P < 0.01). In contrast, when patients receive saline, all hormone levels were significantly higher in patients than in healthy controls (P < 0.01). Heroin-dependent patients showed a normalized HPA axis response compared to healthy controls when they receive their regular heroin dose. These findings indicate that regular opioid administration protects addicts from stress and underscore the clinical significance of heroin-assisted treatment for heroin-dependent patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Drug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
The role of stress in drug self-administration
Piazza, P. V., & Le Moal, M. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01115-2 · Cited by 673
Psychological stress, drug-related cues and cocaine craving
Sinha, R., Fuse, T., Aubin, L.-R., & O'Malley, S. S. (2000) · Psychopharmacology · doi:10.1007/s002130000499 · Cited by 463
Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction
Oviedo-Joekes, E., Brissette, S., Marsh, D. C., Lauzon, P., Guh, D., Anis, A., & Schechter, M. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810635 · Cited by 375
Kreek, M. J., LaForge, K. S., & Butelman, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd897 · Cited by 374
Sinha, R., Talih, M., Malison, R., Cooney, N., Anderson, G. M., & Kreek, M. J. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1525-8 · Cited by 366
Drug addiction: Pathways to the disease and pathophysiological perspectives
Le Moal, M., & Koob, G. F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.10.006 · Cited by 283
KREEK, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06683.x · Cited by 258
Cognitive concepts of craving.
Tiffany, S. T. (1999) · PubMed Central · Cited by 256
Acute Effect of Methadone Maintenance Dose on Brain fMRI Response to Heroin-Related Cues
Langleben, D. D., Ruparel, K., Elman, I., Busch-Winokur, S., Pratiwadi, R., Loughead, J., O’Brien, C. P., & Childress, A. R. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07010070 · Cited by 217
Stress and relapse to drug seeking in rats: studies on the generality of the effect
Shalev, U., Highfield, D., Yap, J., & Shaham, Y. (2000) · Psychopharmacology · doi:10.1007/s002130000441 · Cited by 197
Fox, H. C., Talih, M., Malison, R., Anderson, G. M., Kreek, M. J., & Sinha, R. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.05.002 · Cited by 164
Opiates, opioids and addiction.
Kreek, M. J. (1996) · PubMed · Cited by 126
Kling, M. A., Carson, R. E., Borg, L., Zametkin, A., Matochik, J. A., Schluger, J., Herscovitch, P., Rice, K. C., Ho, A., Eckelman, W. C., et al. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39007-x · Cited by 119
Heroin-assisted treatment in Switzerland: a case study in policy change.
Uchtenhagen, A. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02741.x · Cited by 109
Neuroendocrine pathways of addictive behaviour
F, K., & K, W. (2004) · Addiction Biology · doi:10.1080/13556210412331292532 · Cited by 107
Soyka, M., Apelt, S. M., Lieb, M., & Wittchen, H.-U. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000245561.99036.49 · Cited by 63
Schluger, J. H., Bart, G. B., Green, M., Ho, A., & Kreek, M. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300156 · Cited by 57
Schuster, C. R., Greenwald, M. K., Johanson, C.-E., & Heishman, S. J. (1995) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.3.4.424 · Cited by 53
Mei, W., Zhang, J. X., & Xiao, Z. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.07.033 · Cited by 50
Walter, M., Gerhard, U., Gerlach, M., Weijers, H., Boening, J., & Wiesbeck, G. A. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00018.x · Cited by 48
Self-citationMcKay, J. R., Alterman, A. I., Mulvaney, F. D., & Koppenhaver, J. M. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00013-7 · Cited by 45
Broadbear, J. H., Winger, G. D., Cicero, T. J., & Woods, J. H. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38316-8 · Cited by 45
Stohler, R., Dürsteler, K. M., Stoermer, R., Seifritz, E., Hug, I. P., Sattler-Mayr, J., Müller-Spahn, F., Ladewig, D., & Höck, C. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00036-8 · Cited by 39
Walter, M., Wiesbeck, G. A., Nicole Bloch, G., Aeschbach, S., Olbrich, H. M., Seifritz, E., & Dürsteler‐MacFarland, K. M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.005 · Cited by 35
Self-citationHeroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients
Walter, M., Wiesbeck, G. A., Degen, B., Albrich, J., Oppel, M., Schulz, A., Schächinger, H., & Dürsteler-MacFarland, K. M. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00205.x · Cited by 34
Self-citationBrown, T. T., Wisniewski, A. B., & Dobs, A. S. (2006) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2006.130.135 · Cited by 30
Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine
Dürsteler‐MacFarland, K. M., Stohler, R., Moldovanyi, A., Rey, S., Basdekis‐Jozsa, R., Gschwend, P., Eschmann, S., & Rehm, J. T. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.07.004 · Cited by 28
Cerebral blood flow effects of acute intravenous heroin administration
Kosel, M., Noss, R. S., Hämmig, R., Wielepp, P., Bundeli, P., Heidbreder, R., Kinser, J. A., Brenneisen, R., Fisch, H., Kayser, S., et al. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.11.007 · Cited by 23
Self-citationAouizerate, B., Ho, A., Schluger, J. H., Perret, G., Borg, L., Le Moal, M., Piazza, P. V., & Kreek, M. J. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00006.x · Cited by 21
Gerber, H., Borgwardt, S. J., Schmid, O., Gerhard, U., Joechle, W., Riecher-Rössler, A., Wiesbeck, G. A., & Walter, M. (2012) · European Addiction Research · doi:10.1159/000334411 · Cited by 20
Self-citationStrasser, J., Wiesbeck, G. A., Meier, N., Stohler, R., & Dürsteler‐MacFarland, K. M. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181e6df49 · Cited by 16
Self-citationBourquin, D., Bundeli, P., Lehmann, T., & Brenneisen, R. (1999) · Journal of Liquid Chromatography & Related Technologies · doi:10.1081/jlc-100102050 · Cited by 13
Self-citation
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Schmidt, A., Borgwardt, S., Gerber, H., Wiesbeck, G. A., Schmid, O., Riecher‐Rössler, A., Smieskova, R., Lang, U. E., & Walter, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.019 · Cited by 129
Self-citationAssociation of opioid misuse with anxiety and depression: A systematic review of the literature
Rogers, A. H., Zvolensky, M. J., Ditre, J. W., Buckner, J. D., & Asmundson, G. J. G. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.101978 · Cited by 97
Reduced Volume of the Nucleus Accumbens in Heroin Addiction
Seifert, C. L., Magon, S., Sprenger, T., Lang, U. E., Huber, C. G., Denier, N., Vogel, M., Schmidt, A., Radue, E.-W., Borgwardt, S., et al. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0564-y · Cited by 80
Self-citationSocial defeat stress and escalation of cocaine and alcohol consumption: Focus on CRF
Newman, E. L., Leonard, M. Z., Arena, D. T., de Almeida, R. M. M., & Miczek, K. A. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.09.007 · Cited by 75
Metadata
- Authors
- Walter, M., Gerber, H., Kuhl, H. C., Schmid, O., Joechle, W., Lanz, C., Brenneisen, R., Schächinger, H., Riecher-Rössler, A., Wiesbeck, G. A., & Borgwardt, S. J.
- Affiliations
- University of Basel (CH)
- University of Bern (CH)
- Universität Trier (DE)
- Corresponding author
- Walter, Marc
- Gerber, Hana
- Kuhl, Hans Christian
- Schmid, Otto
- Wiesbeck, Gerhard A.
- Borgwardt, Stefan J.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2013-04
- Volume
- 33
- Issue
- 2
- Pages
- 193-198
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2327692652
- Cited by
- 43
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 7 · 2017: 2 · 2015: 4 · 2014: 8 · 2013: 2
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- green
- edoc.unibas.ch
- Licence
- other-oa
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- edoc (University of Basel) (submittedVersion, other-oa)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (127544, 32003B)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- heroin, heroin addiction, hypothalamic-pituitary-adrenal axis, ACTH, cortisol, heroin-assisted treatment, opioid administration, craving, withdrawal, anxiety, stress response, opioid metabolites
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Chromatography, High Pressure Liquid, Heroin, Double-Blind Method, Female, Heroin Dependence, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Pituitary-Adrenal System, Substance Abuse, Intravenous, Case-Control Studies, Cross-Over Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.